Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study

BACKGROUND: Hydroxychloroquine has not been associated with improved survival among hospitalized COVID-19 patients in the majority of observational studies and similarly was not identified as an effective prophylaxis following exposure in a prospective randomized trial. We aimed to explore the role...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Infect Dis
Main Authors: Ip, Andrew, Ahn, Jaeil, Zhou, Yizhao, Goy, Andre H., Hansen, Eric, Pecora, Andrew L., Sinclaire, Brittany A., Bednarz, Urszula, Marafelias, Michael, Sawczuk, Ihor S., Underwood, Joseph P., Walker, David M., Prasad, Rajiv, Sweeney, Robert L., Ponce, Marie G., La Capra, Samuel, Cunningham, Frank J., Calise, Arthur G., Pulver, Bradley L., Ruocco, Dominic, Mojares, Greggory E., Eagan, Michael P., Ziontz, Kristy L., Mastrokyriakos, Paul, Goldberg, Stuart L.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807228/
https://ncbi.nlm.nih.gov/pubmed/33446136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-021-05773-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados